Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22149286 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL14747331 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL14568397 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL15892307 | 1.00 | CA2 (0.38) | CA2CA1CA9 | |
| SCHEMBL23288108 | 0.87 | CA2 (0.47) | CA2CA1CA9 | |
| SCHEMBL12230182 | 0.87 | CA2 (0.47) | CA2CA1CA9 | |
| SCHEMBL18009708 | 0.87 | CA2 (0.47) | CA2CA1CA9 | |
| SCHEMBL24079389 | 0.87 | CA2 (0.47) | CA2CA1CA9 | |
| SCHEMBL15432496 | 0.87 | CA2 (0.47) | CA2CA1CA9 | |
| SCHEMBL15574116 | 0.87 | CA2 (0.47) | CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150191446-A1 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | THE HEART RESEARCH INSTITUTE LTD (AU) | 2015-07-09 | — | — | US | disclosed |
| US-20140206658-A1 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | THE HEART RESEARCH INSTITUTE LTD. (AU) | 2014-07-24 | — | — | US | disclosed |
| US-20070185063-A1 | Seven-membered ring nucleosides | IDENIX PHARMACEUTICALS, INC. | 2007-08-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150191446-A1 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | GPX1, MPO, GPX4 | CA2 1766/4885CA1 804/4885CA9 1626/4885 |
| US-20140206658-A1 | SELENO-COMPOUNDS AND THERAPEUTIC USES THEREOF | MPO, GPX1, GPX4 | CA2 1962/4885CA1 1303/4885CA9 2613/4885 |
| US-20070185063-A1 | Seven-membered ring nucleosides | NSUN2, NSUN3, HAVCR2 | CA2 4878/4885CA1 4851/4885CA9 4619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.